By H.S. AyoubBioHealth Investor.com I wrote earlier about the anti-vaccination movement, and how Merck (MRK) has been receiving a lot of backlash because of its lobbying efforts. Merck (MRK) has been lobbying pretty hard…
Pharmacyclics, Inc. (PCYC-NASDAQ) is trading down over 40% pre-market after receiving a ‘refuse to file’ letter from the FDA for its new drug application for Xcytrin® Injection for the treatment of non-small cell lung…
by H.S. AyoubBioHealth Investor.com Shares of Novadel (NVD), a BHI Stock Pick, lost 13% in after hours trading on Tuesday following an announcement by Hana Biosciences (HNAB) that the launch of Zensana will be…
by H.S. AyoubBioHealth Investor.com While investors must research the history of any company’s management and executives, it is even more imperative in the biotech industry. Cutting edge medical research is both risky and expensive,…
NovaBay Pharmaceuticals has filed to come public via an IPO, although this one is being put on the American Stock Exchange instead of NASDAQ or NYSE. It will also trade in Canada on the…
Over the last five years, the shares of Genentech (DNA) have risen about 275%. Shares in Amgen (AMGN) are not up as much but they have performed about as well as the Dow. Is…
by H.S. AyoubBioHealth Investor.com The Business, a British business magazine, published an article early January on rumors that Pfizer (PFE) may have contacted NovaDel Pharma (NVD) to initiate research into the development of a…
Shares in Illumina (ILMN), a company that makes chips and tools for testing genetic variations, are up 5% to $36.70 on 14 million shares. The company made two announcements. One is that it will…
By Chad Brand of Peridot Capitalist Pharmacy chain CVS (CVS) has increased its bid for Caremark (CMX) by $4 per share in an attempt to secure the pharmacy benefits manager. Rather than simply raise…